Neurotech Pharmaceuticals, Inc.
Julie (Julieta) Sousa is a seasoned quality assurance professional with extensive experience in the biotechnology and pharmaceutical industries. Currently serving as QA Principal at Neurotech Pharmaceuticals, Inc. since June 2022, Sousa previously held positions including Quality Assurance Specialist III at Celldex Therapeutics and QA Compliance Specialist at Allergan. Notable expertise includes overseeing change control systems, providing operational support for Quality functions, managing batch release processes, and ensuring laboratory GMP compliance. Sousa's career spans various roles in quality control and assurance, starting from a Staff Scientist at Advanced Technologies and Regenerative Medicine to QC Supervisor positions at Stryker Biotech. Julie holds a Bachelor of Science in Biology from the University of Massachusetts Dartmouth.
Neurotech Pharmaceuticals, Inc.
Neurotech Pharmaceuticals, Inc. is a privately held biotech company located in Cumberland, Rhode Island. Neurotech has spent years developing the science, technology, team and manufacturing behind NT-501. As a result of a unique partnership and clear direction, we are focused on bringing a long-term treatment to Macular Telangiectasia (MacTel) patients. Our team is focused on bringing to market this treatment designed to slow the progression of MacTel and the vision impairments it causes in patients who don't have another treatment option. Our goal is to help these patients sustain their quality of life.